June 2024 in “Archives of dermatological research” Both treatments work, but Minoxidil 0.5% MMP® is better for certain scalp areas and less advanced hair loss.
June 2023 in “Skin Research and Technology” Using platelet-rich plasma injections and 5% minoxidil topically can safely and effectively treat mild-to-moderate male pattern baldness.
1 citations
,
January 1998 in “Seminars in Plastic Surgery” Hair transplantation using micro- and minigraft megasessions is safe, effective, and provides natural results with high patient satisfaction.
25 citations
,
January 2017 in “Steroids” Allopregnanolone increases growth and changes gene activity in human brain cancer cells.
37 citations
,
May 2007 in “International Journal of Pharmaceutics” PPCM microspheres allow controlled finasteride release over 24 hours.
January 2021 in “Springer eBooks” Combining PRP with other treatments can improve hair loss outcomes.
April 2012 in “The Journal of Urology” Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.
37 citations
,
February 2014 in “Journal of Dermatology” Valproic acid increases hair count in men with hair loss.
1 citations
,
May 2024 in “Human Genomics” Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.
April 2024 in “MRIMS journal of health sciences” Using growth factor injections and minoxidil together can significantly improve hair growth in people with hair loss.
July 2022 in “Hair transplant forum international” Finasteride is effective and safe for long-term use in treating hair loss in Japanese men.
Multiphoton microscopy helps understand and improve vitiligo treatments by visualizing skin cell changes.
Polydopamine is promising for personalized medicine and biomedical technology due to its strong adhesion and biocompatibility.
1 citations
,
January 2021 in “PubMed” Four PRP with microneedling sessions effectively treat androgenetic alopecia.
14 citations
,
June 2021 in “British Journal of Dermatology” The BIOMAP glossary standardizes data to improve research on atopic dermatitis and psoriasis.
November 2022 in “The journal of investigative dermatology/Journal of investigative dermatology” A patient with a new PLEC gene mutation showed symptoms of both muscular dystrophy and myasthenia gravis, which improved with steroid treatment.
April 2019 in “The Journal of Urology” Some common medications can lower PSA levels in 45-year-old German men.
June 2021 in “Aesthetic Surgery Journal” PRP improves hair growth in AGA, but higher concentrations aren't significantly better than lower ones.
99 citations
,
January 2004 in “Journal of Biological Chemistry” Methylprednisolone helps skin cells stick together better in pemphigus vulgaris.
5 citations
,
April 2016 in “PubMed” Young men with mild hair loss who experience significant social and emotional distress are more likely to have sexual problems.
August 2024 in “Repozitorij Farmaceutsko-biokemijskog fakulteta (Sveučilišta u Zagrebu)” The gel can effectively deliver melatonin through the skin.
November 2025 in “Molecular and Cellular Biomedical Sciences” There is no significant link between the MMP-1 rs1799750 polymorphism and androgenetic alopecia in the Indonesian population.
December 2015 in “PLOS Genetics” 1 citations
,
June 2022 in “Photobiomodulation, photomedicine, and laser surgery” Photobiomodulation increases hair density in 5 weeks for androgenetic alopecia.
August 2003 in “Journal of Investigative Dermatology” Phosphatidic acid may promote hair growth like minoxidil.
November 2021 in “International Journal of Trichology” Low PON1 levels may indicate and predict the severity of hair loss.
July 2023 in “Indian Journal of Postgraduate Dermatology” Higher PSA levels can indicate prostate cancer, but there's overlap with non-cancerous conditions.
May 2009 in “OPAL (Open@LaTrobe) (La Trobe University)” Suppressing the HGPS mutation may improve symptoms and suggest reversibility.
April 2023 in “Journal of Investigative Dermatology” Psoriasis patients did not show more brain atrophy or small vessel disease than controls, but longer psoriasis duration was linked to more brain atrophy.